List of Tables
Table 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Crizotinib
Table 3. Key Players of Alectinib
Table 4. Key Players of Ceritinib
Table 5. Key Players of Brigatinib
Table 6. Key Players of Other
Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Region (2020-2025)
Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Region (2026-2031)
Table 13. ALK Positive Lung Cancer Treatment Market Trends
Table 14. ALK Positive Lung Cancer Treatment Market Drivers
Table 15. ALK Positive Lung Cancer Treatment Market Challenges
Table 16. ALK Positive Lung Cancer Treatment Market Restraints
Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global ALK Positive Lung Cancer Treatment Market Share by Players (2020-2025)
Table 19. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2024)
Table 20. Ranking of Global Top ALK Positive Lung Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of ALK Positive Lung Cancer Treatment, Headquarters and Area Served
Table 23. Global Key Players of ALK Positive Lung Cancer Treatment, Product and Application
Table 24. Global Key Players of ALK Positive Lung Cancer Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global ALK Positive Lung Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America ALK Positive Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. F. Hoffmann-La Roche Company Details
Table 50. F. Hoffmann-La Roche Business Overview
Table 51. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product
Table 52. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 53. F. Hoffmann-La Roche Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer ALK Positive Lung Cancer Treatment Product
Table 57. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis ALK Positive Lung Cancer Treatment Product
Table 62. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. TP Therapeutics Company Details
Table 65. TP Therapeutics Business Overview
Table 66. TP Therapeutics ALK Positive Lung Cancer Treatment Product
Table 67. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 68. TP Therapeutics Recent Development
Table 69. Bristol-Myers Squibb Company Details
Table 70. Bristol-Myers Squibb Business Overview
Table 71. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product
Table 72. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 73. Bristol-Myers Squibb Recent Development
Table 74. Eli Lilly and Company Company Details
Table 75. Eli Lilly and Company Business Overview
Table 76. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product
Table 77. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 78. Eli Lilly and Company Recent Development
Table 79. Takeda Company Details
Table 80. Takeda Business Overview
Table 81. Takeda ALK Positive Lung Cancer Treatment Product
Table 82. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 83. Takeda Recent Development
Table 84. Beacon Pharma Company Details
Table 85. Beacon Pharma Business Overview
Table 86. Beacon Pharma ALK Positive Lung Cancer Treatment Product
Table 87. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 88. Beacon Pharma Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. ALK Positive Lung Cancer Treatment Picture
Figure 2. Global ALK Positive Lung Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Crizotinib Features
Figure 5. Alectinib Features
Figure 6. Ceritinib Features
Figure 7. Brigatinib Features
Figure 8. Other Features
Figure 9. Global ALK Positive Lung Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global ALK Positive Lung Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinics Case Studies
Figure 13. Other Case Studies
Figure 14. ALK Positive Lung Cancer Treatment Report Years Considered
Figure 15. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global ALK Positive Lung Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global ALK Positive Lung Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2024
Figure 19. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2024
Figure 21. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America ALK Positive Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 23. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe ALK Positive Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 27. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Region (2020-2031)
Figure 35. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America ALK Positive Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 43. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 47. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE ALK Positive Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 53. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 55. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 56. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 57. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
